Zalutsky, M. R., Reardon, D. A., Quinn, J. A., Coleman, R. E., Akabani, G., Friedman, A. H., … Bigner, D. D. (2006). Chimeric murine/human IgG(2) anti-tenascin 81C6 monoclonal antibody: phase I trial in patients with malignant glioma of a construct with improved stability. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 33, S194–S194.

Zalutsky, M. R., D. A. Reardon, J. A. Quinn, R. E. Coleman, G. Akabani, A. H. Friedman, H. S. Friedman, et al. “Chimeric murine/human IgG(2) anti-tenascin 81C6 monoclonal antibody: phase I trial in patients with malignant glioma of a construct with improved stability.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 33 (September 1, 2006): S194–S194.

Zalutsky MR, Reardon DA, Quinn JA, Coleman RE, Akabani G, Friedman AH, et al. Chimeric murine/human IgG(2) anti-tenascin 81C6 monoclonal antibody: phase I trial in patients with malignant glioma of a construct with improved stability. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2006 Sep 1;33:S194–S194.

Zalutsky, M. R., et al. “Chimeric murine/human IgG(2) anti-tenascin 81C6 monoclonal antibody: phase I trial in patients with malignant glioma of a construct with improved stability.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 33, SPRINGER, Sept. 2006, pp. S194–S194.

Zalutsky MR, Reardon DA, Quinn JA, Coleman RE, Akabani G, Friedman AH, Friedman HS, Herndon JE, McLendon RE, Wong TZ, Bigner DD. Chimeric murine/human IgG(2) anti-tenascin 81C6 monoclonal antibody: phase I trial in patients with malignant glioma of a construct with improved stability. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2006 Sep 1;33:S194–S194.